Echo IQ is trading at A$1.67, +5.38% now; no new company announcement or reliable report directly explaining the August 12, 2026 move was found.

  • Investor attention may still reflect the pending FDA review of EchoSolv HF following the August 5 510(k) submission, which included clinical-validation results.
  • Trading activity and volume details for the current move were unavailable.